Pazobrite 400 Tablet
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Pazopanib (400mg)
Overview Pazobrite 400 Tablet
Sorafenib 400mg tablets function as a protein kinase inhibitor, indicated for kidney cancer and soft-tissue sarcoma treatment. Administer this medication on an empty stomach, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose may lead to severe adverse effects. Therapeutic benefits may not be apparent immediately; continue treatment unless instructed otherwise by your doctor. Common side effects include diarrhea and hypertension. Your physician may recommend regular blood pressure monitoring. Manage diarrhea with increased fluid intake or consult your doctor if it persists. This medication can lower blood cell counts, increasing infection risk; report fever, flu-like symptoms, or shortness of breath immediately. Inform your doctor of any pre-existing heart, liver, or kidney conditions, or concurrent use of infection-fighting medications before commencing treatment. This medication interacts with many other drugs; disclose all medications to your healthcare provider. Avoid pregnancy during treatment; effective contraception is crucial for both men and women.
Uses of Pazobrite 400 Tablet
Renal cell carcinoma or soft tissue sarcoma.
Major Benefits of Pazobrite 400 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Pazobrite 400mg tablets should be taken on an empty stomach.
Common Side effects of Pazobrite 400 Tablet:
- Headache
- Nausea
- Vomiting
- Musculoskeletal (bone, muscle or joint) pain
- Fatigue
- Change in color of hair
- Diarrhea
- High blood pressure
- Decreased appetite
- Weight loss
- Taste change
- Abnormal skin pigmentation
- Hair discoloration
- Tumor pain
- Breathlessness
How to use Pazobrite 400 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Pazobrite 400 Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Pazobrite 400 Tablet works:
Pazobrite 400mg tablets are an anticancer drug. Their mechanism of action involves targeting and blocking tyrosine kinase enzyme receptors, crucial for cancerous cell multiplication. The medication also prevents the development of new blood vessels supplying the tumor, thus hindering its growth and spread.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Pazobrite 400 Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Pazobrite 400 Tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Nevertheless, a physician might exceptionally prescribe it in emergencies where the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Nursing mothers should avoid Pazobrite 400 Tablets. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Taking Pazobrite 400 Tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Pazobrite 400mg tablets can be administered to patients with renal impairment without requiring a modification of the dosage.
LiverCAUTION
Patients with liver impairment should use Pazobrite 400 Tablets cautiously, potentially requiring dosage modification. A physician's consultation is recommended. Pazobrite 400 Tablets are contraindicated for individuals with moderate to severe hepatic dysfunction.
What if you forget to take Pazobrite 400 Tablet :
NA
Facts to Know About Pazobrite 400 Tablet
| Label | Value |
|---|---|
| Chemical Category | Diarylalkylamines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Kinase inhibitors targeting tyrosine |



